Schistosomiasis—a century searching for chemotherapeutic drugs (original) (raw)

• Abo-Madyan AA, Morsy TA, Motawea SM, Morsy AT (2004) Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate. J Egypt Soc Parasitol 34:807–818
  PubMed Google Scholar
• Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402
  PubMed CAS Google Scholar
• Ashton PD, Curwen RS, Wilson RA (2001) Linking proteome and genome: how to identify parasite proteins. Trends Parasitol 17:198–202
  PubMed CAS Google Scholar
• Atalay G, Cardoso F, Awada A, Piccart MJ (2003) Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol 14:1346–1363
  PubMed CAS Google Scholar
• Balde AM, Van Marck EA, Kestens L, Gigase PL, Vlietinck AJ (1989) Schistosomicidal effects of Pavetta owariensis and Harrisonia abyssinica in mice infected with Schistosoma mansoni. Planta Med 55:41–43
  PubMed CAS Google Scholar
• Barth LR, Fernandes AP, Ribeiro-Paes JT, Rodrigues V (1997) Effects of goyazensolide during in vitro cultivation of Schistosoma mansoni. Mem Inst Oswaldo Cruz 92:427–429
  PubMed CAS Google Scholar
• Basch PF, Clemens LE (1989) Schistosoma mansoni: reversible destruction of testes by procarbazine. Comp Biochem Physiol C 93:397–401
  PubMed CAS Google Scholar
• Baselga J (2002) Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing. Ann Oncol 13:8–9
  PubMed CAS Google Scholar
• Becker B, Mehlhorn H, Andrews P, Thomas H (1981) Ultrastructural investigations on the effect of praziquantel on the tegument of five species of cestodes. Z Parasitenkd 64:257–269
  PubMed CAS Google Scholar
• Benson AB 3rd (1993) Oltipraz: a laboratory and clinical review. J Cell Biochem Suppl 17F:278–291
  PubMed Google Scholar
• Bergquist NR (1995) Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswaldo Cruz 90:221–227
  PubMed CAS Google Scholar
• Bergquist NR (2002) Schistosomiasis: from risk assessment to control. Trends Parasitol 18:309–314
  PubMed Google Scholar
• Bergquist R, Utzinger J, Chollet J, Shu-Hua X, Weiss NA, Tanner M (2004) Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model. Am J Trop Med Hyg 71:774–777
  PubMed CAS Google Scholar
• Bhisutthibhan J, Meshnick SR (2001) Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies. Antimicrob Agents Chemother 45:2397–2399
  PubMed CAS Google Scholar
• Bhisutthibhan J, Pan XQ, Hossler PA, Walker DJ, Yowell CA, Carlton J, Dame JB, Meshnick SR (1998) The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem 273:16192–16198
  PubMed CAS Google Scholar
• Bickle QD, Andrews BJ (1985) Resistance following drug attenuation (Ro 11-3128 or oxamniquine) of early Schistosoma mansoni infections in mice. Parasitology 90(Pt 2):325–338
  PubMed Google Scholar
• Bickle QD, Sacko M, Vignali DA (1990) Induction of immunity against Schistosoma mansoni by drug (Ro11-3128)-terminated infections: analysis of surface antigen recognition. Parasite Immunol 12:569–586
  PubMed CAS Google Scholar
• Bonn D (2004) Schistosomiasis: a new target for calcium-channel blockers? Lancet Infect Dis 4:190
  PubMed Google Scholar
• Boros DL (1989) Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev 2:250–269
  PubMed CAS Google Scholar
• Botros S, William S, Hammam O, Zidek Z, Holy A (2003) Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice. Antimicrob Agents Chemother 47:3853–3858
  PubMed CAS Google Scholar
• Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M, Hassanein M, El-Wahab YA, Engels D (2005) Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. Am J Trop Med Hyg 72:119–123
  PubMed CAS Google Scholar
• Bout D, Deslee D, Capron A (1986) Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni. Infect Immun 52:823–827
  PubMed CAS Google Scholar
• Bueding E, Batzinger R, Petterson G (1976) Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540). Experientia 32:604–606
  PubMed CAS Google Scholar
• Bueding E, Hawkins J, Cha YN (1981) Antischistosomal effects of cyclosporin A. Agents Actions 11:380–383
  PubMed CAS Google Scholar
• Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL (2003) A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Cancer Res 63:8912–8921
  PubMed CAS Google Scholar
• Chen GZ, Foster L, Bennett JL (1990) Antischistosomal action of mevinolin: evidence that 3-hydroxy-methylglutaryl-coenzyme a reductase activity in Schistosoma mansoni is vital for parasite survival. Naunyn Schmiedebergs Arch Pharmacol 342:477–482
  PubMed CAS Google Scholar
• Cioli D (2000) Praziquantel: is there real resistance and are there alternatives? Curr Opin Infect Dis 13:659–663
  PubMed CAS Google Scholar
• Cioli D, Pica-Mattoccia L, Archer S (1995) Antischistosomal drugs: past, present ... and future? Pharmacol Ther 68:35–85
  PubMed CAS Google Scholar
• Costa G, Aguiar BG, Coelho PM, Cunha-Melo JR (2003) On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine. Acta Trop 89:13–16
  PubMed CAS Google Scholar
• Dillon GP, Feltwell T, Skelton JP, Ashton PD, Coulson PS, Quail MA, Nikolaidou-Katsaridou N, Wilson RA, Ivens AC (2006) Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni. Int J Parasitol 36:1–8
  PubMed CAS Google Scholar
• Dunsford HA, Keysser CH, Dolan PM, Seed JL, Bueding E (1984) Carcinogenicity of the antischistosomal nitrofuran trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole. J Natl Cancer Inst 73:151–160
  PubMed CAS Google Scholar
• Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957–961
  PubMed CAS Google Scholar
• El Baz MA, Morsy TA, El Bandary MM, Motawea SM (2003) Clinical and parasitological studies on the efficacy of Mirazid in treatment of schistosomiasis haematobium in Tatoon, Etsa Center, El Fayoum Governorate. J Egypt Soc Parasitol 33:761–776
  PubMed Google Scholar
• el Kouni MH, Diop D, O’Shea P, Carlisle R, Sommadossi JP (1989). Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5′-monophosphate for the treatment of schistosomiasis. Antimicrob Agents Chemother 33:824–827
  PubMed Google Scholar
• Feldmeier H, Chitsulo L (1999) Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection. Arzneimittelforschung 49:557–565
  PubMed CAS Google Scholar
• Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509–515
  PubMed CAS Google Scholar
• Ferrari ML, Coelho PM, Antunes CM, Tavares CA, da Cunha AS (2003) Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ 81:190–196
  PubMed CAS Google Scholar
• Fetterer RH, Pax RA, Bennett JL (1980) Praziquantel, potassium and 2,4-dinitrophenol: analysis of their action on the musculature of Schistosoma mansoni. Eur J Pharmacol 64:31–38
  PubMed CAS Google Scholar
• Fitzpatrick JM, Johnston DA, Williams GW, Williams DJ, Freeman TC, Dunne DW, Hoffmann KF (2005) An oligonucleotide microarray for transcriptome analysis of Schistosoma mansoni and its application/use to investigate gender-associated gene expression. Mol Biochem Parasitol 141:1–13
  PubMed CAS Google Scholar
• Gönnert R, Andrews P (1977) Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenkd 52:129–150
  PubMed Google Scholar
• Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA (2002) Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol 62:1364–1372
  PubMed CAS Google Scholar
• Greenberg RM (2005) Are Ca2+ channels targets of praziquantel action? Int J Parasitol 35:1–9
  PubMed CAS Google Scholar
• Gunasekera AM, Patankar S, Schug J, Eisen G, Wirth DF (2003) Drug-induced alterations in gene expression of the asexual blood forms of Plasmodium falciparum. Mol Microbiol 50:1229–1239
  PubMed CAS Google Scholar
• Harder A (2002a) Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 88:395–397
  PubMed CAS Google Scholar
• Harder A (2002b) Milestones of helmintic research at Bayer. Parasitol Res 88:477–480
  PubMed CAS Google Scholar
• Hardjawidjaja L, Clark RT, Sorensen K, Putrali J (1976) Drug trial of Schistosoma japonicum enfection in Indonesia. Southeast Asian J Trop Med Public Health 7:314–318
  PubMed CAS Google Scholar
• Harnett W, Kusel JR (1986) Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 93(Pt 2):401–405
  PubMed CAS Google Scholar
• Hassan M, El-Motaiem M, Afify H, Abaza B, El-Shafei M, Massoud AM (2003) In vitro effect of Mirazid on Schistosoma mansoni worms. J Egypt Soc Parasitol 33:999–1008
  PubMed Google Scholar
• Haynes RK, Monti D, Taramelli D, Basilico N, Parapini S, Olliaro P (2003) Artemisinin antimalarials do not inhibit hemozoin formation. Antimicrob Agents Chemother 47:1175
  PubMed CAS Google Scholar
• Hoffmann KF, Dunne DW (2003) Characterization of the Schistosoma transcriptome opens up the world of helminth genomics. Genome Biol 5:203
  PubMed Google Scholar
• Holy A, Votruba I, Merta A, Cerny J, Vesely J, Vlach J, Sediva K, Rosenberg I, Otmar M, Hrebabecky H et al (1990) Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res 13:295–311
  PubMed CAS Google Scholar
• Hu W, Yan Q, Shen DK, Liu F, Zhu ZD, Song HD, Xu XR, Wang ZJ, Rong YP, Zeng LC, Wu J, Zhang X, Wang JJ, Xu XN, Wang SY, Fu G, Zhang XL, Wang ZQ, Brindley PJ, McManus DP, Xue CL, Feng Z, Chen Z, Han ZG (2003) Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 35:139–147
  PubMed Google Scholar
• Huffman MA (2001) Self-medicative behavior in the African great apes: an evolutionary perspective into the origins of human traditional medicine. BioScience 51:651–661
  Google Scholar
• Kannan R, Kumar K, Sahal D, Kukreti S, Chauhan VS (2005) Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochem J 385:409–418
  PubMed CAS Google Scholar
• Kayser O, Olbrich C, Croft SL, Kiderlen AF (2003a) Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs. Parasitol Res 90(Suppl 2):S63–S670
  PubMed Google Scholar
• Kayser O, Kiderlen AF, Croft SL (2003b) Natural products as antiparasitic drugs. Parasitol Res 90(Suppl 2):S55–S62
  PubMed Google Scholar
• Khattab A, Pica-Mattoccia L, Klinkert MQ, Wenger R, Cioli D (1998) Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity. Exp Parasitol 90:103–109
  PubMed CAS Google Scholar
• Kikuth W, Goennert R (1948) Experimental studies on the therapy of schistosomiasis. Ann Trop Med Parasitol 42:256–267
  PubMed CAS Google Scholar
• Kloos H, David R (2002) The paleoepidemiology of schistosomiasis in ancient Egypt. Hum Ecol Rev 9:14–25
  Google Scholar
• Kohn AB, Anderson PA, Roberts-Misterly JM, Greenberg RM (2001) Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J Biol Chem 276:36873–36876
  PubMed CAS Google Scholar
• Kohn A, Roberts-Misterly J, Anderson P, Khan N, Greenberg R (2003) Specific sites in the beta interaction domain of a schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel. Parasitology 127:349–356
  PubMed CAS Google Scholar
• Kramata P, Votruba I, Otova B, Holy A (1996) Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon. Mol Pharmacol 49:1005–1011
  PubMed CAS Google Scholar
• Magnussen P (2003) Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years’ experiences. Acta Trop 86:243–254
  PubMed CAS Google Scholar
• Massoud AM, El Ebiary FH, Abd El Salam NF (2004) Effect of myrrh extract on the liver of normal and bilharzially infected mice. An ultrastructural study. J Egypt Soc Parasitol 34:1–21
  PubMed Google Scholar
• Matsuyama H, Takahashi H, Watanabe K, Fujimaki Y, Aoki Y (2004) The involvement of cyclic adenosine monophosphate in the control of schistosome miracidium cilia. J Parasitol 90:8–14
  PubMed CAS Google Scholar
• McManus DP, Hu W, Brindley PJ, Feng Z, Han ZG (2004) Schistosome transcriptome analysis at the cutting edge. Trends Parasitol 20:301–304
  PubMed CAS Google Scholar
• Mehlhorn H, Becker B, Andrews P, Thomas H, Frenkel JK (1981) In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study. Arzneimittelforschung 31:544–554
  PubMed CAS Google Scholar
• Melo AL, Silva-Barcellos NM, Demicheli C, Frezard F (2003) Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes. Int J Pharm 255:227–230
  PubMed Google Scholar
• Meshnick SR (2002) Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32:1655–1660
  PubMed CAS Google Scholar
• Meshnick SR, Taylor TE, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 60:301–315
  PubMed CAS Google Scholar
• Moczon T, Swiderski Z (1992) Schistosoma haematobium: histochemistry of glycogen, glycogen phosphorylase a and glycogen branching enzyme in niridazole-treated females. Int J Parasitol 22:55–63
  PubMed CAS Google Scholar
• N’Goran EK, Utzinger J, Gnaka HN, Yapi A, N’Guessan NA, Kigbafori SD, Lengeler C, Chollet J, Shuhua X, Tanner M (2003) Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg 68:24–32
  PubMed CAS Google Scholar
• Nontprasert A, Pukrittayakamee S, Dondorp AM, Clemens R, Looareesuwan S, White NJ (2002a) Neuropathologic toxicity of artemisinin derivatives in a mouse model. Am J Trop Med Hyg 67:423–429
  PubMed CAS Google Scholar
• Nontprasert A, Pukrittayakamee S, Prakongpan S, Supanaranond W, Looareesuwan S, White NJ (2002b) Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Trans R Soc Trop Med Hyg 96:99–101
  PubMed CAS Google Scholar
• Ogboli A (2000) Medicinal application of Vernonia amygdalina del leaf extracts in the treatment of schistosomiasis in mice. Niger J Nat Prod Med 4:73–75
  Google Scholar
• Olds GR, Dasarathy S (2000) Schistosomiasis. Curr Treat Options Infect Dis 2:88–99
  Google Scholar
• Oliveira MF, Silva JR, Dansa-Petretski M, de Souza W, Braga CM, Masuda H, Oliveira PL (2000) Haemozoin formation in the midgut of the blood-sucking insect Rhodnius prolixus. FEBS Lett 477:95–98
  PubMed CAS Google Scholar
• Oliveira MF, d’Avila JC, Tempone AJ, Soares JB, Rumjanek FD, Ferreira-Pereira A, Ferreira ST, Oliveira PL (2004) Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection. J Infect Dis 190:843–852
  PubMed CAS Google Scholar
• Oliveira MF, Kycia SW, Gomez A, Kosar AJ, Bohle DS, Hempelmann E, Menezes D, Vannier-Santos MA, Oliveira PL, Ferreira ST (2005) Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus. FEBS Lett 579:6010–6016
  PubMed CAS Google Scholar
• O’Neill PM, Bray PG, Hawley SR, Ward SA, Park BK (1998) 4-Aminoquinolines—past, present, and future: a chemical perspective. Pharmacol Ther 77:29–58
  PubMed CAS Google Scholar
• Pandey AV, Tekwani BL, Singh RL, Chauhan VS (1999) Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem 274:19383–19388
  PubMed CAS Google Scholar
• Penido ML, Nelson DL, Vieira LQ, Coelho PM (1994) Schistosomicidal activity of alkylaminooctanethiosulfuric acids. Mem Inst Oswaldo Cruz 89:595–602
  Article PubMed CAS Google Scholar
• Penido ML, Coelho PM, Nelson DL (1999) Efficacy of a new schistosomicidal agent 2-[(methylpropyl)amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate. Mem Inst Oswaldo Cruz 94:811–813
  PubMed CAS Google Scholar
• Pereira LH, Coelho PM, Costa JO, de Mello RT (1995) Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni. Mem Inst Oswaldo Cruz 90:425–428
  PubMed CAS Google Scholar
• Pica-Mattoccia L, Cioli D (1985) Studies on the mode of action of oxamniquine and related schistosomicidal drugs. Am J Trop Med Hyg 34:112–118
  PubMed CAS Google Scholar
• Rao KV, Chen L, Gnanasekar M, Ramaswamy K (2002) Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J Biol Chem 277:31207–31213
  PubMed CAS Google Scholar
• Rege AA, Wang W, Dresden MH (1992) Cysteine proteinases from Schistosoma haematobium adult worms. J Parasitol 78:16–23
  PubMed CAS Google Scholar
• Roca C, Balanzo X, Gascon J, Fernandez-Roure JL, Vinuesa T, Valls ME, Sauca G, Corachan M (2002) Comparative, clinico-epidemiologic study of Schistosoma mansoni infections in travellers and immigrants in Spain. Eur J Clin Microbiol Infect Dis 21:219–223
  PubMed CAS Google Scholar
• Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP (2002) Schistosomiasis. N Engl J Med 346:1212–1220
  PubMed Google Scholar
• Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61:294–303
  PubMed CAS Google Scholar
• Santos AJ (1976) Prevalence and distribution of schistosomiasis in the Philippines: a review. Southeast Asian J Trop Med Public Health 7:133–136
  PubMed Google Scholar
• Shaw MK (1990) Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel. Parasitology 100(Pt 1):65–72
  Article PubMed CAS Google Scholar
• Sheir Z, Nasr AA, Massoud A, Salama O, Badra GA, El-Shennawy H, Hassan N, Hammad SM (2001) A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg 65:124–700
  Google Scholar
• Shekhar KC (1991) Schistosomiasis drug therapy and treatment considerations. Drugs 42:379–405
  Article PubMed CAS Google Scholar
• Silva IM, Thiengo R, Conceicao MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC (2005) Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Mem Inst Oswaldo Cruz 100:445–449
  PubMed Google Scholar
• Smeijsters LJ, Nieuwenhuijs H, Hermsen RC, Dorrestein GM, Franssen FF, Overdulve JP (1996) Antimalarial and toxic effects of the acyclic nucleoside phosphonate (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine in Plasmodium berghei-infected mice. Antimicrob Agents Chemother 40:1584–1588
  PubMed CAS Google Scholar
• Smith DA, Bickle QD, Kaye PM (1994) Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation. Immunology 82:419–426
  PubMed CAS Google Scholar
• Soliman MF, Ibrahim MM (2005) Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. Acta Trop 93:1–9
  PubMed CAS Google Scholar
• Striebel HP (1976) 4-Isothiocyanato-4′-nitrodiphenylamine (C 9333-Go/CGP 4540), an anthelminthic with an unusual spectrum of activity against intestinal nematodes, filariae and schistosomes. Experientia 32:457–458
  PubMed CAS Google Scholar
• Sulaiman SM, Ali HM, Homeida MM, Bennett JL (1989) Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops). Trop Med Parasitol 40:335–336
  PubMed CAS Google Scholar
• Sullivan DJ (2002) Theories on malarial pigment formation and quinoline action. Int J Parasitol 32:1645–1653
  PubMed CAS Google Scholar
• Sullivan DJ Jr, Gluzman IY, Russell DG, Goldberg DE (1996) On the molecular mechanism of chloroquine’s antimalarial action. Proc Natl Acad Sci U S A 93:11865–11870
  PubMed CAS Google Scholar
• Talla E, de Mendonca RL, Degand I, Goffeau A, Ghislain M (1998) Schistosoma mansoni Ca2+-ATPase SMA2 restores viability to yeast Ca2+-ATPase-deficient strains and functions in calcineurin-mediated Ca2+ tolerance. J Biol Chem 273:27831–27840
  PubMed CAS Google Scholar
• Thomas SM, Grandis JR (2004) Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat Rev 30:255–268
  PubMed CAS Google Scholar
• Utzinger J, Xiao S, Keiser J, Chen M, Zheng J, Tanner M (2001) Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr Med Chem 8:1841–1860
  PubMed CAS Google Scholar
• Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47:1487–1495
  PubMed CAS Google Scholar
• Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, Paquola AC, Piazza JP, Nishiyama MY Jr, Kitajima JP, Adamson RE, Ashton PD, Bonaldo MF, Coulson PS, Dillon GP, Farias LP, Gregorio SP, Ho PL, Leite RA, Malaquias LC, Marques RC, Miyasato PA, Nascimento AL, Ohlweiler FP, Reis EM, Ribeiro MA, Sa RG, Stukart GC, Soares MB, Gargioni C, Kawano T, Rodrigues V, Madeira AM, Wilson RA, Menck CF, Setubal JC, Leite LC, Dias-Neto E (2003) Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 35:148–157
  PubMed Google Scholar
• Verjovski-Almeida S, Leite LC, Dias-Neto E, Menck CF, Wilson RA (2004) Schistosome transcriptome: insights and perspectives for functional genomics. Trends Parasitol 20:304–308
  PubMed CAS Google Scholar
• Vicogne J, Dissous C (2003) Schistosoma mansoni receptor tyrosine kinases: towards new therapeutic targets. J Soc Biol 197:367–373
  PubMed CAS Google Scholar
• Vicogne J, Pin JP, Lardans V, Capron M, Noel C, Dissous C (2003) An unusual receptor tyrosine kinase of Schistosoma mansoni contains a Venus Flytrap module. Mol Biochem Parasitol 126:51–62
  PubMed CAS Google Scholar
• Votruba I, Bernaerts R, Sakuma T, De Clercq E, Merta A, Rosenberg I, Holy A (1987) Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis. Mol Pharmacol 32:524–529
  PubMed CAS Google Scholar
• Walter RD, Albiez EJ (1984) Interaction of amoscanate with the cyclic AMP-phosphodiesterases from Schistosoma mansoni, Onchocerca volvulus and bovine heart. Tropenmed Parasitol 35:78–80
  PubMed CAS Google Scholar
• Wasilewski MM, Lim KC, Phillips J, McKerrow JH (1996) Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol Biochem Parasitol 81:179–189
  PubMed CAS Google Scholar
• WHO (2002) TDR Strategic direction for research. Disease TDR Strategic direction for research. Disease burden and epidemiological trends. http://www.who.int/tdr/diseases/schisto/direction.htm
• WHO–Geneva (2002) WHO technical report series 912: prevention and control of schistosomiasis and soil-transmitted helminthiasis. WHO, Geneva
  Google Scholar
• Wu GY, Halim MH (2000) Schistosomiasis: progress and problems. World J Gastroenterol 6:12–19
  PubMed Google Scholar
• Xiao S, Utzinger J, Chollet J, Endriss Y, N’Goran EK, Tanner M (2000) Effect of artemether against Schistosoma haematobium in experimentally infected hamsters. Int J Parasitol 30:1001–1006
  PubMed CAS Google Scholar
• Xiao SH, Yue WJ, Yang YQ, You JQ (1987) Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Chin Med J (Engl) 100:759–768
  CAS Google Scholar
• Xiao S, Shen B, Chollet J, Utzinger J, Tanner M (2001) Tegumental alterations in juvenile Schistosoma haematobium harboured in hamsters following artemether treatment. Parasitol Int 50:175–183
  PubMed CAS Google Scholar
• Xiao SH, Wu YL, Tanner M, Wu WM, Utzinger J, Mei JY, Scorneaux B, Chollet J, Zhai Z (2003) Schistosoma japonicum: in vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media. Parasitol Res 89:459–466
  PubMed Google Scholar
• Xiao SH, Guo J, Chollet J, Wu JT, Tanner M, Utzinger J (2004) Effect of artemether on Schistosoma mansoni: dose–efficacy relationship, and changes in worm morphology and histopathology. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 22:148–153
  PubMed Google Scholar
• Zerda KS, Dresden MH, Chappell CL (1988) Schistosoma mansoni: expression and role of cysteine proteinases in developing schistosomula. Exp Parasitol 67:238–246
  PubMed CAS Google Scholar